Skip to main content

PTC Therapeutics, Inc.

PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070081

In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 384 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 16, 2026
$5.09B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $7.75M in total
10
13F holdersQ2 2026, +32 vs. previous quarter
384
13F valueReported value at the end of Q2 2026
$8.20B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$1.73B
+114.5% year over year
Net income, FY2025
$682.6M
No comparable prior period
Free cash flow, FY2025
$702.3M
No comparable prior period
Revenue, Q3 FY2026
$357.8M
+69.6% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
7.78M
Shares sold short
Change
−524.0K
−6.3% vs. previous
Days to cover
7.50
At average daily volume

Superinvestors holding PTCT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PTCT at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by PTC Therapeutics, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 16, 2026 (view filing)5:20 PM ETOct 142 daysSchmertzler MichaelDirectorSSale−2.50K$59.61−$149.0K−0.2%1.29M after2 lots10b5-1
Oct 13, 2026 (view filing)5:20 PM ETOct 94 daysBoulding Mark ElliottEXEC. VP AND CLOSSale−192$64.26−$12.3K−0.2%105.3K after10b5-1
Oct 9, 2026 (view filing)5:20 PM ETOct 72 daysSchmertzler MichaelDirectorSSale−2.50K$63.39−$158.5K−0.2%1.29M after2 lots10b5-1
Oct 7, 2026 (view filing)5:20 PM ETOct 5-62 daysBoulding Mark ElliottEXEC. VP AND CLOSSale−2.07K$64.06−$132.8K−1.9%105.3K after2 lots10b5-1
Oct 2, 2026 (view filing)5:20 PM ETSep 302 daysSteele Glenn Jr MD PhDDirectorSSale−12.0K$65.16−$781.9K−34.8%22.5K after10b5-1
Sep 18, 2026 (view filing)5:20 PM ETSep 16-172 daysSchmertzler MichaelDirectorSSale−20.0K$67.49−$1.35M−1.5%1.30M after4 lots10b5-1
Sep 11, 2026 (view filing)5:20 PM ETSep 9-102 daysSchmertzler MichaelDirectorSSale−20.0K$67.59−$1.35M−1.5%1.32M after3 lots10b5-1
Aug 28, 2026 (view filing)5:20 PM ETAug 26-272 daysSchmertzler MichaelDirectorSSale−25.0K$72.26−$1.81M−1.8%1.34M after4 lots10b5-1
Aug 21, 2026 (view filing)5:20 PM ETAug 19-202 daysSchmertzler MichaelDirectorSSale−25.0K$72.22−$1.81M−1.8%1.36M after5 lots10b5-1
Aug 19, 2026 (view filing)5:20 PM ETAug 172 daysBoulding Mark ElliottEXEC. VP AND CLOSSale−2.81K$72.57−$204.1K−2.6%105.3K after2 lots10b5-1

Top 10 13F holders, Q2 2026

See all 384 holders

The largest institutional positions in PTC Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding PTCT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.13,964,554$1.14B0.02%+1,015,837+7.8%Added
RTW Investments, LP7,746,415$631.9M5.39%00.0%Unchanged
Jupiter Topco LLC7,236,402$590.2M0.24%+7,236,402New
Vanguard Portfolio Management LLC4,928,111$402.0M0.02%+123,517+2.6%Added
State Street Corp4,598,952$375.1M0.01%+252,433+5.8%Added
Wellington Management Group LLP4,128,273$336.7M0.06%+185,663+4.7%Added
Vanguard Capital Management LLC3,739,127$305.0M0.01%+62,871+1.7%Added
Geode Capital Management, LLC2,207,376$180.1M0.01%−2,578−0.1%Reduced
Toronto Dominion Bank2,165,846$176.7M0.29%−860,117−28.4%Reduced
Westfield Capital Management Co LP1,956,156$159.6M0.52%+1,956,156New

Holders of 5% or more of PTCT

See all 6 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of PTC Therapeutics, Inc..

Largest holders of PTCT from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A14.80%11.9M shares+6.80 ppfrom 8.00%Apr 17, 20252 filingsDec 4, 2025SEC
Janus Henderson Group PLC13G/A8.70%7.19M shares+2.70 ppfrom 6.00%Feb 11, 20224 filingsMay 15, 2026SEC
State Street Corp13G6.60%5.51M shares+1.40 ppfrom 5.20%Jan 24, 20244 filingsNov 10, 2026SEC
Wellington Management Group LLP13G6.30%5.29M shares+1.50 ppfrom 4.80%Feb 4, 20218 filingsNov 16, 2026SEC
Vanguard Portfolio Management LLC13G5.88%4.87M sharesNewApr 29, 20261 filingApr 29, 2026SEC